All posts by medical

The Anatomy of Hope – artist Rita Duffy on her new animation – RTE.ie

Trinity College Artist In Residence,Rita Duffy writes for Culture about her latest project, The Anatomy Of Hope, a stunninganimation featuring original music by Rory Pierce, and dedicatedto the late Art O'Brain- watch it above.

Back in the spring, during the early part of my residency at Trinity and through the initial shock of Covid 19, I made drawings. Images of vulnerable human hearts and lungs appeared and from somewhere the spring flowers floated in through the window to ease the mortal despair - they became memorials to people dying by cell phone.

Through the summer months, the drawings continued; a resilient brain wears a daisy chain crown, we will survive this pandemic and live to tell the tale. Lungs appear wearing west of Ireland shawls, like gossiping women.

Finally, as we approach the darkness of winter, challenged by the hardest part of our collective struggle. I've arrived at a point where the drawings are segueing one into another, hope and fear colliding. Using this concept and adding to the visual material, I began the 'animated drawing process.

I reach back to the ageless rituals of Bridgit, the cloak that gathers us in, safe in its shelter, wishing trees and holy wells and cures, dark shadowy places filled with magic and hope.

The heart is pulsing, pumping out through vessels and hedgerow tangle, colour creeps across the page, covid blackberries sprouting, lungs inhaling. Teeth clench and bare, thorny briars encroach, a talisman to keep us safe and vaccine tied to a branch as amulet. Discarded blue gloves tumble like autumn leaves, a language of fingers and spring flowers promising to carry us through, imaging ourselves better.

The robust heartfelt kindness, experienced in Irish communities reassures me, all will be well. Ourselves alone, the ghost of a memory flits through my head. Superstitious ribbons and St Bridget's red rags impaled on thorns, - suffering on, offering it up, enduring at all costs - doing the right thing. Amulets threaded with nostalgia plead for a better future, a borderless place both snug and wide open a doorway never needing to be closed.

I want to imagine not the threat of freedom or its tentative, grasping fragility, but the concrete thrill of borderlessness.

And once again I find myself inspired by the African American struggle, and the words of James Baldwin:Love takes off the masks that we fear we cannot live without and know we cannot live within.'

Read more:
The Anatomy of Hope - artist Rita Duffy on her new animation - RTE.ie

Neuroscience institute renovating building The Daily Evergreen – The Daily Evergreen

Building located in Spokane; resources provided from the institute available to students on all WSU campuses

COURTESY OF WASHINGTON STATE UNIVERSITY HEALTH SCIENCES

The building will be outfitted with specific technology to help people with neurodegenerative diseases. The institute will start accepting patients at the end of the summer.

The Steve Gleason Institute for Neuroscience is renovating a building on the WSU Spokane campus.

Avista Development owns the building, which is located south of WSU Health Sciences, at 325 E. Sprague Ave. Avista leases it to the institute for a nominal fee, according to the WSU Health Sciences Spokane website.

The pandemic has slowed the renovation progress, but the building is nearing completion. Renovations started last summer, and should be finished in three to four months, said Andrea Lazarus, executive director of the Steve Gleason Institute for Neuroscience.

Upon completion, the building will be outfitted with specific technology to help people with neurodegenerative diseases. The institute will start accepting patients at the end of the summer, Lazarus said.

A lot of patients with ALS get diagnosed and may not see their physician again right away, Lazarus said. They dont know where to go. We are a resource where they can come and find out more information about their condition.

Avista and the Health Sciences and Services Authority of Spokane County helped fund the renovation, said Daryll B. DeWald, vice president and chancellor of WSU Health Sciences.

Although the physical building is located in Spokane, resources provided from the institute will be available to students on all WSU campuses, Lazarus said.

The institute plans on hosting a number of informative seminars, she said. They will also bring together WSU neuroscience students across all campuses to collaborate on various research projects.

There is a lot of ongoing neuroscience research at WSU, but it hasnt been all brought together under one umbrella, Lazarus said, And that is what we are hoping to do.

The institute has a tripartite mission, DeWald said. This means they will focus on clinical services, research and student engagement with technology.

The three focuses set the institute apart from others like it because many have a combination of clinical and research experience, but lack innovative and adaptive technology, Lazarus said.

The institute uses technology like eye trackers to help people with ALS communicate, De Wald said.

I am motivated, personally, to serve, to build and to try to address these diseases and understand how they work, he said.

Lazarus said the institute partnered and is co-branding with St. Lukes Rehabilitation Institute. St. Lukes treats patients with neurodegenerative diseases, like ALS.

The institute collaborates with St. Lukes to outfit patients with technology that will help them manage their specific diseases, she said.

Lazarus said if the building is a success, they hope to build a second building later on to expand research opportunities and increase the number of patients they can serve.

Read this article:
Neuroscience institute renovating building The Daily Evergreen - The Daily Evergreen

Studying What She Loves Japanese and Neuroscience – News – Hamilton College News

Back when she was college hunting, Maya Taliaferro 21 thought Hamilton and its open curriculum looked like a perfect fit for pursuing her disparate interests of Japanese and neuroscience. Now a senior, Taliaferro is convinced she made the right choice.

She was able to major in neuroscience, minor in Japanese and balance her science major with a semester of off-campus study in Kyoto, Japan. The timing of the program she attended proved to be lucky it started a bit early, which meant she squeezed in most of the experience before it was short by the COVID-19 pandemic.

Major: Neuroscience

Minor: Japanese

Hometown:Ambler, Pa.

High School:Wissahickon High School

Studying in Japan was a highlight of her college career. It's one of the things that really drew me towards Hamilton because I knew that they had a strong study abroad program and really good financial support for study abroad, said Taliaferro, who received a Benjamin A. Gilman International Scholarship.

While she was abroad she had an opportunity to work in a biology lab. So I was still able to keep up with some of the scientific stuff that I like to do, and do that in Japan and practice my Japanese. It was really the perfect mix. It was really awesome, she said.

After Taliaferro graduates from Hamilton, her plan is to get a research job for two years before she enters a neuroscience doctoral program in the U.S.

But I love Japan, and I love the experience I had there. And so I never want to lose my interaction with it. I have a couple of friends from Japan that I made when I was there that I want to continue to keep in contact with. But in terms of career, after grad school, I would definitely consider jobs in Japan as well as in the United States, she said.

At Hamilton students may major or minor in Japanese.

Read more:
Studying What She Loves Japanese and Neuroscience - News - Hamilton College News

Pasadena: Whats that Amazing Building on the Corner of Del Mar and Wilson? – coloradoboulevard.net

South side of Tianqiao and Chrissy Chen Neuroscience Research Building (Photo Caltech.edu)

By Kate Bartlett

The Tianqiao and Chrissy Chen Neuroscience Research Building (CNRB) was dedicated on January 29, 2021. Virtual attendees included more than 850 Caltech leaders, researchers, students, alumni and friends. The 150,000 square-foot luminous copper building contains research and teaching laboratories, a 150-seat lecture hall and a neurotechnology center in which grad students and postdocs can set up complicated experiments requiring system engineering, measurement of behavior,stimuli observation and new software. The expansive windows provide sunlight to the teaching and conference rooms, and the human-focused gathering spaces feature skylights and gardens.

The CNRB houses the Chen Institute of Neuroscience, as well as faculty and researchers from other disciplines; before the completion of the CNRB, neuroscience labs were located primarily in the Beckmann Behavioral Building, Kirchoff Building, Moore Building and Broad Institute. The open design between the second and third floors makes interaction easier and promotes imaginative research, according to David Anderson, Professor of Biology and Director of the Chen Institute.

The Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech originally was born from a chance encounter with a news report on the ability to control a robotic arm using only a persons mind. Tianqiao Chan and his wife, Chrissy Luo, created the Institute to allow researchers to jumpstart new projects while the CNRB was under construction.

Caltech researchers probe the circuitry, cells and molecular, chemical and electrical pathways of the brain, pursue the neurological basis of personality, develop new brain imaging technique, map brain circuits, develop neurotechnology to treat brain disorders, investigate social cognition and emotions in humans, and quantify behaviors and correlate them to brain activity.

Viviana Gradinaru, professor of neuroscience and biological engineering and director the Center for Molecular and Cellular Neuroscience, said the Chen Institute is like a trampoline:

In science, we have to make leaps of faith. We have to jump high, and you jump much higher on a trampolineespecially one that has a safety net thats big enough and welcoming of others and other opinions. This is what the Chen family provided us.

Colorado Boulevard.net is your place for enlightening events, informative news and social living for the greater Pasadena area. We strive to inform, educate, and work together to make a better world for all of us, locally and globally.

Follow this link:
Pasadena: Whats that Amazing Building on the Corner of Del Mar and Wilson? - coloradoboulevard.net

Iowa and Ohio researchers discover compound with the potential to protect prenatal brain development – UI The Daily Iowan

A new study done in mice by researchers in Iowa and Ohio shows that a relatively new compound, P7C3-A20, has the ability to protect brain development during prenatal stress.

Contributed.

Photo of Director of Translational Neuroscience in the Department of Psychiatry Andrew Pieper.

As a generation of babies are born in the middle of a global crisis, researchers in Iowa and Ohio discovered a compound with the potential to protect babies brain development from the harmful impacts of prenatal stress.

When babies are exposed to adverse stressful events during pregnancy, it can prevent their brains from developing properly. The new research conducted in baby mice could be a game-changer in combating the negative impacts of prenatal stress.

Hanna Stevens, who heads the Psychiatry and Early Neurobiological Development Lab at the University of Iowa Carver College of Medicine, said there is data suggesting individuals exposed to prenatal stress are at higher risk for specific disorders later in life.

Theres been evidence that theres greater likelihood of diagnosis with Attention Deficit Disorder, Autism Spectrum Disorder, and anxiety disorders, Stevens said.

Stevens added that exposure to prenatal stress can increase an individuals risk for various other disorders as well, depending on an individuals unique biological reaction to stressful events during pregnancy.

Its not so much the kind of stress that a person experiences, but sort of their biological response, Stevens said.

UI graduate student Rachel Schroeder, who is studying neuroscience at the UI, said the project began about four years ago when she was inspired by the individual work of her two mentors, Stevens and Director of Translational Neuroscience in the Department of Psychiatry Andrew Pieper, during her first year of graduate school.

I was thinking, you know, a lot of these phenotypes that I am seeing in the Stevens lab due to prenatal stress are lining up with things that they are fixing in the Pieper lab with this compound, Schroeder said.

Stevens said the compound was proven to be effective at reversing the impacts of prenatal stress within the brains of baby mice.

RELATED:University of Iowa researchers develop mice model to study COVID-19 symptoms

[Schroeder] found that brain developmental genes were changed by the stress experience and then were again corrected by the compound, Stevens said.

Schroeder said while this compound is still relatively new and its mechanisms are not fully understood, it seems to work by replenishing the levels of NAD that are available to cells.

NAD is a very important molecule for energy metabolism, Schroeder said. So, if you dont have enough energy, that can lead to damage in a number of different ways.

Pieper, who is also an adjunct professor at the UI and Director of the Neurotherapeutics Center at Harrington Discovery Institute in Cleveland, is the groups expert on the compound itself.

Pieper said he is optimistic about the potential effectiveness of administering P7C3-A20 to humans, considering its success in mice. P7C3-A20 is the scientific name for the neuroprotective compound that Pieper studies.

We have given it to mice, to rats, and monkeys for extended periods of time, and in some cases, up to a year, Pieper said. We havent seen any side effects so far in our animal models, so that makes me optimistic.

However, Pieper said promising trial results in other species do not guarantee how well the compound will work when it is tested in human subjects.

Schroeder said that it will take much time before the compound is approved for usage in humans and eventually made available to pregnant mothers.

Its a very, very long process and it is really difficult to develop a drug and get it all the way to the bedside, even in a single lifetime, Schroeder said.

View original post here:
Iowa and Ohio researchers discover compound with the potential to protect prenatal brain development - UI The Daily Iowan

Sensor helps scientists spy on serotonin activity in mice in real time – Spectrum

Your browser does not support the video tag.Pause

A new engineered protein that glows in the presence of serotonin enables researchers to track the neurotransmitters levels and location in the brains of living mice, according to a new study. This serotonin sensor could help elucidate serotonins role in autism, experts say.

Serotonin helps regulate mood, circulation and digestion, among other functions. Some people with autism have elevated levels of serotonin in their blood. Other evidence links serotonin to social behavior in mice.

Serotonin is wildly important both for basic research and human health. And for the longest time, ways to measure it were very indirect, says co-lead researcher Loren Looger, professor of neuroscience at the University of California, San Diego. Only with sensors like this can one follow it in vivo, which is critical.

Unlike other tools for measuring serotonin, the sensor can also show changes in serotonin activity over time, making it an exciting tool for autism research, says Jeremy Veenstra-VanderWeele, professor of psychiatry at Columbia University, who was not involved in the study.

This tool will make it possible to understand the relationships between serotonin release and complex behaviors, including in different genetic mouse models related to autism, he says. I imagine that this tool will come into fairly broad use.

The new sensor originated from one described last year that detects a different neurotransmitter, acetylcholine. Looger and his team used a computer algorithm to redesign the acetylcholine-binding portion of the sensor protein so that it could attach to serotonin instead.

To test the design, the team used a hollowed virus to insert the gene encoding the protein into the striatum of mice. Two weeks later, they viewed slices from the striatum a hub for serotonin activity and saw the proteins green glow. Electrically stimulating neurons in the slices to release serotonin increased the glow, as did bathing the slices in serotonin.

The researchers also injected the sensor-delivering virus into brain regions that are regulated by serotonin namely, the amygdala and prefrontal cortex. These two regions process fear. The team trained the mice to associate a sound and light with a mild electric shock to the foot. Optical recordings of the animals neurons showed a rise in serotonin while the sound and light played, followed by a sharp dip when the shock arrived.

Happy glow: An engineered protein lights up in the brains of mice when their neurons release mood-modulating serotonin.

Image courtesy of Elizabeth Unger and video courtesy of Chunyang Dong and Elizabeth Unger

In a third test, they injected the sensor into these same two brain areas in the mice, as well as the bed nucleus of the stria terminalis, which is involved in stress responses and social behaviors. Live recordings of groups of neurons showed serotonin release in all three brain areas during social interactions with an unfamiliar mouse. Animals that had access to an exercise wheel for six weeks before the interactions an activity known to ease stress showed even higher serotonin spikes in the prefrontal cortex.

The sensor also revealed levels of serotonin in the animals brains, glowing in step with electrical recordings of their serotonin neurons: Serotonin activity rose when the animals woke and dropped as they transitioned through certain stages of sleep.

The work appeared in December in Cell.

The serotonin sensor could offer new insights into previously observed behaviors in mouse models of autism, Veenstra-VanderWeele says.

For instance, for mice to prefer social stimuli over being alone, they must release serotonin in the nucleus accumbens, a brain area involved in processing social reward, according to a 2018 study. Artificially increasing serotonin levels in this brain region restores social behavior in an autism mouse model.

The serotonin sensor could provide researchers with an opportunity to look at the actual pattern of release thats involved in shaping that sort of preference, Veenstra-VanderWeele says.

The brains of most animals use serotonin in similar ways, so the tool might also illuminate the neurotransmitters role in autistic people and could help pave the way for more effective treatments.

The ability to detect serotonin in the brain is a really useful tool for translational neuroscience, says Gl Dlen, associate professor of neuroscience at Johns Hopkins University in Baltimore, Maryland, who was not involved in the work. Serotonin is an evolutionarily ancient neurotransmitter that has been implicated in encoding social behaviors in a wide variety of species, which has the potential to be targeted for treating social impairments in autism.

For now, the sensor is not sensitive to small bursts of serotonin, Looger says. His team plans to improve its sensitivity going forward.

Read the original post:
Sensor helps scientists spy on serotonin activity in mice in real time - Spectrum

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and…

23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics  PRNewswire

See the original post here:
23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and...

Can Fulgent Genetics Inc (FLGT) Stock Rise to the Top of Healthcare Sector? – InvestorsObserver

The 99 rating InvestorsObserver gives to Fulgent Genetics Inc (FLGT) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 86 percent of stocks in the Healthcare sector, FLGTs 99 overall rating means the stock scores better than 99 of all stocks.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Fulgent Genetics Inc (FLGT) stock is trading at $128.63 as of 10:05 AM on Wednesday, Feb 3, an increase of $15.79, or 14% from the previous closing price of $112.83. The stock has traded between $118.81 and $132.83 so far today. Volume today is below average. So far 343,509 shares have traded compared to average volume of 2,419,433 shares.

Click Here to get the full Stock Score Report on Fulgent Genetics Inc (FLGT) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

Read more from the original source:
Can Fulgent Genetics Inc (FLGT) Stock Rise to the Top of Healthcare Sector? - InvestorsObserver

Genetic testing company 23andMe to go public via merger with Richard Branson’s SPAC in $3.5 billion deal – MarketWatch

23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp. VGAC, +1.74%, in a deal with an enterprise value of about $3.5 billion, the companies said Thursday. SPACs,or blank-check companies, raise money in an initial public offering and then have two years to acquire a business or businesses. They have become a popular vehicle for IPOs during the pandemic. Once the deal has closed, the company will change its ticker symbol to "ME" and trade on the New York Stock Exchange. 23andMe co-Founder Anne Wojcicki and Branson are investing $25 million in the company, which will have a pro forma cash balance of more than $900 million at closing. 23andMe offers individuals the chance to have their genes tested, providing them with information on health risks and ancestry. "Through a genetics-based approach, we fundamentally believe we can transform the continuum of healthcare.," Wojcicki said in a statement. The deal is expected to close in the second quarter. VG Acquisition shares jumped 12% premarket on the news.

Read the rest here:
Genetic testing company 23andMe to go public via merger with Richard Branson's SPAC in $3.5 billion deal - MarketWatch

Paw Print Genetics Launches 46 New Tests for Inherited Diseases and Traits Found in Canines – PRNewswire

SPOKANE, Wash., Feb. 1, 2021 /PRNewswire/ --Paw Print Genetics, a division of Genetic Veterinary Sciences, Inc., has launched 46 new, highly desired disease and trait tests to their ever-growing menu of genetic assays. This menu now consists of nearly 300 different tests for over 350 different breeds of dog, the largest in the industry.

Among these are new tests for Labrador retrievers, Beagles, Collies and many other breeds. All tests offered at Paw Print Genetics are based on the published, medical literature, and developed and validated in their laboratory in Spokane, WA.

"We are very excited to provide these tests to our customer community of breeders, veterinarians and dog owners." stated Dr. Lisa Shaffer, CEO of Paw Print Genetics. "By offering the largest menu of tests available, Paw Print Genetics continues to be the leading provider of testing for genetic conditions in dogs. With our staff of geneticists and veterinarians, we provide genetic counseling services to fully support our customers in their testing."

These additional tests further Paw Print Genetics' mission to help breeders achieve optimal canine genetic health. Paw Print Genetics strictly follows the published standards and guidelines for canine clinical genetic testing laboratories.As such, all testing conducted by Paw Print Genetics is performed in duplicate with two independent methods, ensuring a 99.9% accuracy rate.

Learn more about these new test offerings here: https://www.pawprintgenetics.com/blog/2021/01/28/paw-print-genetics-launches-46-new-tests-dogs/

About Paw Print Genetics

Located in Spokane, Washington, Paw Print Genetics was founded in 2012 and is dedicated to raising the standard in canine genetic diagnostic testing, carrier screening, and customer support. Paw Print Genetics' mission is to achieve optimal canine genetic health by providing outstanding resources for dog owners, breeders, trainers, and veterinarians for pets, show dogs and working dogs. For more information, visit https://www.pawprintgenetics.com/

For more information regarding this topic, please contact Jessica Pieros at [emailprotected].

Contact: Jessica Pieros 509-483-5950 [emailprotected]

SOURCE Paw Print Genetics

View original post here:
Paw Print Genetics Launches 46 New Tests for Inherited Diseases and Traits Found in Canines - PRNewswire